Pet Diabetes Care Devices Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, End Use, Device Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Pet Diabetes Care Devices Market size stood at USD 2.45 Billion in 2026 and is predicted to grow at 7% CAGR from 2027 to 2036, exceeding USD 4.82 Billion by 2036. The industry revenue for 2027 is assessed at USD 2.6 Billion.
Get more details on this report
Request Free Sample ReportPet Diabetes Care Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 43.46% in 2026, driven by strong pet healthcare spending, developed veterinary infrastructure, and growing adoption of glucose monitoring technologies.
- Asia Pacific is the fastest-growing region as urban pet ownership, household spending capacity, veterinary services, and awareness of chronic pet conditions increase.
Segment Momentum
- Dogs represented 58.19% of the market in 2026, driven by higher diabetes diagnosis rates and strong demand for long-term glucose monitoring and insulin administration supported by growing pet health awareness.
- Glucose monitoring devices are projected to grow the fastest as veterinarians and pet owners increasingly prioritize continuous monitoring, treatment optimization, and user-friendly technologies for diabetes management.
Market Expansion Drivers
- Rising pet diabetes prevalence driving demand for continuous glucose monitoring solutions
- Increasing pet healthcare expenditure supporting advanced diagnostic device adoption
- Expansion of connected veterinary diagnostics enabling remote pet metabolic monitoring solutions
Leading Market Participants
- Top companies in the pet diabetes care devices market include Zoetis Inc. (USA), Merck Animal Health (USA), Boehringer Ingelheim (Germany), Elanco Animal Health (USA), Becton, Dickinson and Company (USA), ALR Technologies Inc. (Canada), TaiDoc Technology Corporation (Taiwan), FitBark Inc. (USA), Henry Schein, Inc. (USA), Allison Medical (USA)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.45 Billion
- 2027 Estimated Market Size: USD 2.6 Billion
- Projected Market Size: USD 4.82 Billion by 2036
- Growth Forecast: 7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dogs (Animal Type) | Veterinary Hospitals and Clinics (End Use) | Insulin Delivery Devices (Device Type)
- Emerging Opportunity Segment: Cats (Animal Type) | Homecare Settings (End Use) | Glucose Monitoring Devices (Device Type)
Market Growth Drivers and Industry Trends
Rising pet diabetes prevalence driving demand for continuous glucose monitoring solutions
The increasing incidence of diabetes among companion animals is encouraging veterinarians and pet owners to prioritize early diagnosis and consistent disease management. The pet diabetes care devices market growth is driven by rising demand for continuous glucose monitoring solutions that enable frequent tracking of blood glucose levels while reducing the need for repeated invasive testing. These systems support more informed treatment decisions by providing ongoing metabolic data, allowing veterinarians to adjust insulin therapy according to changing health conditions and daily activity patterns while improving monitoring convenience for caregivers.
Increasing pet healthcare expenditure supporting advanced diagnostic device adoption
Growing willingness among pet owners to invest in comprehensive healthcare is accelerating the adoption of sophisticated diagnostic technologies across veterinary practices. Increasing expenditure on animal health will propel the pet diabetes care devices market growth as clinics expand access to advanced monitoring equipment that improves diagnostic accuracy and supports individualized treatment planning. Higher spending also encourages veterinary facilities to modernize their diagnostic capabilities, enabling earlier disease detection, more frequent follow-up assessments, and improved long-term management of chronic metabolic disorders in companion animals.
Expansion of connected veterinary diagnostics enabling remote pet metabolic monitoring solutions
Digital transformation across veterinary healthcare is creating greater opportunities for remote disease management through connected diagnostic ecosystems. As veterinary practices integrate cloud-enabled monitoring platforms and connected medical devices, the pet diabetes care devices market benefits from solutions that allow continuous metabolic monitoring outside clinical settings. Real-time data sharing between pet owners and veterinarians improves treatment oversight, facilitates timely clinical interventions, and supports personalized care strategies for animals requiring ongoing diabetes management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet diabetes prevalence driving demand for continuous glucose monitoring solutions | 2% | Moderate | North America, Europe | High | Near Term |
| Increasing pet healthcare expenditure supporting advanced diagnostic device adoption | 1.5% | Low | North America, Asia Pacific | Medium | Mid Term |
| Expansion of connected veterinary diagnostics enabling remote pet metabolic monitoring solutions | 1% | Low | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the pet diabetes care devices market, North America held the largest share of 43.46% in 2026, reflecting high levels of pet ownership, strong expenditure on companion animal healthcare, and well-developed veterinary infrastructure. Growing awareness of chronic conditions affecting pets is encouraging owners and veterinarians to adopt technologies that support glucose monitoring and ongoing disease management. The availability of specialized veterinary services and increasing emphasis on preventive and home-based pet care are further supporting demand for diabetes management devices. Greater willingness among pet owners to pursue advanced treatment and monitoring options also contributes to the region’s established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region in the pet diabetes care devices market as companion animals increasingly receive more comprehensive healthcare and veterinary services expand across the region. Rising pet ownership in urban areas, improving household spending capacity, and growing awareness of animal health are encouraging greater investment in specialized care. Veterinary infrastructure is also developing, enabling broader access to diagnostic and monitoring technologies. Increasing recognition of chronic pet conditions and the shift toward preventive healthcare are expected to create additional opportunities for diabetes care device adoption.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Veterinary MonitoringThe U.S. pet diabetes care devices market focuses on improving long-term disease management through connected monitoring technologies and accurate insulin administration. Veterinary clinics and pet owners in the U.S. increasingly adopt digital solutions that support routine glucose tracking and treatment management.
Germany 🇩🇪
Precision Veterinary CareGermany prioritizes reliable pet diabetes care devices that improve diagnostic accuracy and long-term disease monitoring. Veterinary professionals in Germany increasingly integrate advanced glucose measurement technologies into routine care to support individualized treatment strategies for companion animals.
Japan 🇯🇵
Companion Animal ManagementJapan emphasizes practical diabetes care solutions that simplify chronic disease management for aging companion animals. Veterinary practices in Japan increasingly adopt user-friendly monitoring devices that enable regular glucose assessment and improve communication with pet owners.
South Korea 🇰🇷
Digital Veterinary SolutionsSouth Korea continues adopting digitally enabled pet diabetes care devices as veterinary services become more technology-oriented. Clinics in South Korea prioritize connected monitoring systems that improve treatment follow-up, clinical efficiency, and owner engagement in disease management.
France 🇫🇷
Preventive Veterinary SupportFrance expands the use of pet diabetes care devices as veterinary providers strengthen preventive and long-term chronic disease services. Veterinary professionals in France increasingly recommend monitoring technologies that encourage consistent glucose management and informed treatment adjustments.
Italy 🇮🇹
Accessible Chronic CareItaly focuses on practical pet diabetes care devices that improve ongoing disease management across companion animal practices. Veterinary clinics in Italy increasingly adopt dependable monitoring and insulin delivery solutions that support routine care while enhancing owner confidence in treatment adherence.
Segment Leadership and Growth Trends
Pet Diabetes Care Devices Market Share (%), Animal Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
The pet diabetes care devices market was led by the dogs segment, which accounted for 58.19% of the market share in 2026. The segment’s dominance is supported by the relatively higher diagnosis rates of diabetes in dogs and the growing willingness of pet owners to invest in long-term disease management. Regular glucose monitoring and insulin administration are essential components of canine diabetes care, driving consistent demand for specialized diabetes management devices. Increasing awareness of pet health and advances in veterinary diagnostics have further contributed to the segment’s strong market position.
Cats are expected to be the fastest-growing animal type segment as awareness of feline diabetes continues to improve among pet owners and veterinary professionals. Rising rates of obesity and age-related health conditions in cats are contributing to a greater focus on early diagnosis and ongoing disease management. As treatment options become more accessible and monitoring technologies become easier to use, adoption of diabetes care devices for feline patients is expected to accelerate.
End Use Segment Analysis: Veterinary Hospitals and Clinics (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)
Veterinary hospitals and clinics represented the largest end-use segment in 2026. These facilities serve as the primary centers for diabetes diagnosis, treatment planning, and ongoing monitoring, making them essential to effective disease management. Access to trained veterinary professionals, specialized equipment, and comprehensive care services continues to drive demand for diabetes care devices within clinical settings.
Homecare settings are projected to witness the fastest growth as pet owners increasingly seek convenient solutions for managing chronic conditions outside veterinary facilities. Advances in user-friendly monitoring and insulin delivery technologies are enabling owners to conduct routine diabetes management at home with greater confidence. The growing emphasis on continuous care, reduced clinic visits, and improved quality of life for pets is supporting the expansion of the homecare segment.
Device Type Segment Analysis: Insulin Delivery Devices (Largest Segment) vs Glucose Monitoring Devices (Fastest-Growing Segment)
In the pet diabetes care devices market, the insulin delivery devices segment held the largest share in 2026. These devices play a central role in diabetes treatment by enabling accurate and consistent insulin administration, which is critical for maintaining stable blood glucose levels in diabetic pets. Continued reliance on insulin therapy as a primary treatment approach has sustained strong demand for delivery devices across veterinary care settings.
The glucose monitoring devices segment is expected to grow at the fastest rate as preventive and continuous disease management gain greater importance in veterinary medicine. Pet owners and veterinarians are increasingly utilizing monitoring technologies to track glucose fluctuations, optimize treatment plans, and improve health outcomes. Technological advancements that enhance monitoring accuracy, convenience, and ease of use are further driving adoption within this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Dogs, Cats, Horses | Dogs | Cats |
| End Use | Veterinary Hospitals and Clinics, Homecare Settings, Others | Veterinary Hospitals and Clinics | Homecare Settings |
| Device Type | Insulin Delivery Devices, Glucose Monitoring Devices | Insulin Delivery Devices | Glucose Monitoring Devices |
Competitive Landscape and Market Positioning
Key companies in the pet diabetes care devices market:
- Zoetis, Inc. (USA)
- Merck Animal Health (USA)
- Boehringer Ingelheim (Germany)
- Elanco Animal Health (USA)
- Becton Dickinson and Company (USA)
- ALR Technologies, Inc. (Canada)
- TaiDoc Technology Corporation (Taiwan)
- FitBark, Inc. (USA)
- Henry Schein, Inc. (USA)
- Allison Medical (USA)
Clinical precision and long-term disease management are becoming the primary forces shaping competition as suppliers expand beyond standalone monitoring and treatment devices toward integrated care solutions for companion animals. Greater emphasis is being placed on improving ease of use for pet owners while supporting more informed clinical decision-making through connected monitoring, data accessibility, and consistent therapeutic performance. Competitive differentiation is increasingly influenced by the ability to deliver reliable device ecosystems that strengthen adherence to treatment protocols and fit seamlessly into evolving veterinary care workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis | Feb-23 | Zoetis launched the AlphaTrak 3 blood glucose monitoring system in the United States, targeting pet diabetes management. The advanced device delivers improved accuracy and usability for veterinarians and owners, enhancing the company's diagnostic portfolio and market position in at-home monitoring solutions. |
| ALR Technologies | Dec-22 | ALR Technologies entered a strategic distribution and co-branding partnership with Covetrus for the GluCurve Pet CGM system. The agreement leverages Covetrus's extensive global distribution network to exclusively supply veterinary clinics with the first continuous glucose monitoring solution designed for cats and dogs. |
| Trividia Health | Sep-20 | Trividia Health introduced the Test Buddy and Healthy Tracks for pets product lines to simplify diabetes management. This commercial expansion introduced user-friendly glucose tracking tools and specialized accessories, strengthening the company's footprint within the pet health segment. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Pet Diabetes Care Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Pet Diabetes Care Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the pet diabetes care devices market?
What are the growth projections for the pet diabetes care devices industry?
How is rising pet diabetes prevalence driving demand for advanced monitoring devices?
Why are connected veterinary diagnostics becoming important in pet diabetes management?
Why do dogs account for the largest share of the pet diabetes care devices market?
Which device type is expected to grow the fastest in the pet diabetes care devices market?
What makes North America the leading market for pet diabetes care devices?
Why is Asia Pacific becoming an important growth market for pet diabetes care devices?
Which companies are driving growth in the pet diabetes care devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization